July 13, 2021 10:49 AM EDT
Coronavirus

Covid-19 roundup: Sci­en­tists in­ves­ti­gate po­ten­tial safe­ty changes to J&J and As­traZeneca vac­cines; WTO lists crit­i­cal in­puts for vac­cine man­u­fac­tur­ing

Josh Sullivan

Sci­en­tists from J&J, As­traZeneca and the Uni­ver­si­ty of Ox­ford are in­ves­ti­gat­ing po­ten­tial mod­i­fi­ca­tions to their Covid-19 vac­cines, to see if it’s pos­si­ble to re­duce or …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Neu­mora's ma­jor de­pres­sion drug flunks first of three Phase 3 tri­als

A look at biotech's year of the megaround

Roche cir­cles back to Chi­na biotech with $80M deal for lung can­cer ADC

Pfiz­er ends work on Sang­amo's he­mo­phil­ia gene ther­a­py, crush­ing biotech's hopes

Flag­ship biotech Va­lo Health ends 2024 with mid-stage fail

No­var­tis ends Phase 1 ra­dio­phar­ma tri­al; Solve Ther­a­peu­tics pur­sues $75M round

A service from the Financial Times